HK1008815A1 - Lyophilized stem cell factor formulations - Google Patents
Lyophilized stem cell factor formulationsInfo
- Publication number
- HK1008815A1 HK1008815A1 HK98109572A HK98109572A HK1008815A1 HK 1008815 A1 HK1008815 A1 HK 1008815A1 HK 98109572 A HK98109572 A HK 98109572A HK 98109572 A HK98109572 A HK 98109572A HK 1008815 A1 HK1008815 A1 HK 1008815A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- stem cell
- cell factor
- lyophilized
- factor formulations
- lyophilized stem
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/172,507 US6288030B1 (en) | 1993-12-22 | 1993-12-22 | Stem cell factor formulations and methods |
PCT/US1994/014739 WO1995017206A1 (fr) | 1993-12-22 | 1994-12-21 | Formulations lyophylisees du facteur des cellules souches |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1008815A1 true HK1008815A1 (en) | 1999-05-21 |
Family
ID=22627993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98109572A HK1008815A1 (en) | 1993-12-22 | 1998-07-31 | Lyophilized stem cell factor formulations |
Country Status (14)
Country | Link |
---|---|
US (4) | US6288030B1 (fr) |
EP (1) | EP0732935B1 (fr) |
CN (1) | CN1105575C (fr) |
AT (1) | ATE173402T1 (fr) |
AU (1) | AU696860B2 (fr) |
CA (1) | CA2182970C (fr) |
DE (1) | DE69414723T2 (fr) |
DK (1) | DK0732935T3 (fr) |
ES (1) | ES2123951T3 (fr) |
HK (1) | HK1008815A1 (fr) |
IL (1) | IL112088A (fr) |
NZ (1) | NZ278252A (fr) |
WO (1) | WO1995017206A1 (fr) |
ZA (1) | ZA9410189B (fr) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
GB9515839D0 (en) * | 1995-08-02 | 1995-10-04 | Q One Biotech Ltd | Feline stem cell factor |
TW518219B (en) * | 1996-04-26 | 2003-01-21 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
US6017876A (en) | 1997-08-15 | 2000-01-25 | Amgen Inc. | Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity |
US6541033B1 (en) | 1998-06-30 | 2003-04-01 | Amgen Inc. | Thermosensitive biodegradable hydrogels for sustained delivery of leptin |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
US6500418B1 (en) * | 1999-02-12 | 2002-12-31 | The Washington University | Stimulating neutrophil function to treat inflammatory bowel disease |
US8106098B2 (en) | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
US6472208B1 (en) * | 1999-12-13 | 2002-10-29 | Héma-Québec | Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
AU2002220209B2 (en) * | 2000-12-06 | 2006-05-25 | Robert J. Hariri | Method of collecting placental stem cells |
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
EP2336301B1 (fr) * | 2001-02-14 | 2014-07-30 | Anthrogenesis Corporation | Placenta post-gravidique de mammifere, son utilisation et cellules souches placentaires correspondantes |
US20030191056A1 (en) | 2002-04-04 | 2003-10-09 | Kenneth Walker | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
JP3963786B2 (ja) * | 2002-06-11 | 2007-08-22 | 富士通株式会社 | 情報処理装置 |
JP2006509770A (ja) * | 2002-11-26 | 2006-03-23 | アンソロジェネシス コーポレーション | 細胞治療学、細胞治療単位、およびそれらを利用した治療法 |
US20040219136A1 (en) * | 2003-02-13 | 2004-11-04 | Hariri Robert J | Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
GB0321337D0 (en) * | 2003-09-11 | 2003-10-15 | Massone Mobile Advertising Sys | Method and system for distributing advertisements |
BRPI0417186A (pt) * | 2003-12-02 | 2007-03-06 | Celgene Corp | método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica |
JP2007517042A (ja) | 2003-12-30 | 2007-06-28 | デュレクト コーポレーション | 活性物質、好ましくはgnrhの制御放出のための、好ましくはpegおよびplgの混合物を含有するポリマーインプラント |
EA012801B1 (ru) | 2005-06-14 | 2009-12-30 | Эмджен Инк. | Самобуферирующиеся композиции белков |
WO2007016562A2 (fr) * | 2005-07-29 | 2007-02-08 | Amgen Inc. | Formulations inhibant l'agregation de proteines |
CA2856662C (fr) | 2005-10-13 | 2017-09-05 | Anthrogenesis Corporation | Immunomodulation realisee avec des cellules souches placentaires |
EP2471907B1 (fr) * | 2005-12-29 | 2018-09-26 | Celularity, Inc. | Populations de cellules souches placentaires |
JP2009521930A (ja) | 2005-12-29 | 2009-06-11 | アントフロゲネシス コーポレーション | 胎盤幹細胞及び第2供給源由来幹細胞の共存培養 |
AR059066A1 (es) | 2006-01-27 | 2008-03-12 | Amgen Inc | Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf) |
EP1854478A1 (fr) * | 2006-05-12 | 2007-11-14 | Cytos Biotechnology AG | Composition vaccinale comprenant des conjugués nicotine-porteur |
NZ576194A (en) | 2006-10-23 | 2012-02-24 | Anthrogenesis Corp | Methods and compositions for treatment of bone defects with placental cell populations |
KR20150039214A (ko) | 2007-02-12 | 2015-04-09 | 안트로제네시스 코포레이션 | 태반 줄기세포를 이용한 염증 질환의 치료 |
US20100172830A1 (en) * | 2007-03-29 | 2010-07-08 | Cellx Inc. | Extraembryonic Tissue cells and method of use thereof |
TWM322542U (en) * | 2007-05-23 | 2007-11-21 | Universal Scient Ind Co Ltd | Testing machine |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
MX2010003217A (es) * | 2007-09-26 | 2010-07-30 | Celgene Cellular Therapeutics | Celulas angiogenicas de perfundido de placenta humana. |
NZ617412A (en) * | 2007-09-28 | 2015-06-26 | Anthrogenesis Corp | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
CA2704746A1 (fr) * | 2007-11-07 | 2009-05-14 | Anthrogenesis Corporation | Utilisation de sang de cordon ombilical pour le traitement de complications de naissance prematuree |
KR20210149904A (ko) * | 2008-08-20 | 2021-12-09 | 안트로제네시스 코포레이션 | 단리된 태반 세포를 사용한 뇌졸중 치료 |
MX2011001990A (es) * | 2008-08-20 | 2011-03-29 | Anthrogenesis Corp | Composiciones mejoradas de celulas y metodos para preparar las mismas. |
CA2734446C (fr) * | 2008-08-22 | 2017-06-20 | Anthrogenesis Corporation | Methodes et compositions pour le traitement de deficits osseux au moyen de populations de cellules placentaires |
CN102282252B (zh) | 2008-11-19 | 2017-07-04 | 人类起源公司 | 羊膜来源的贴壁细胞 |
EP2375907B1 (fr) * | 2008-11-21 | 2019-02-27 | Celularity, Inc. | Traitement de maladies, troubles ou états du poumon utilisant des cellules placentaires |
NZ619359A (en) | 2009-07-02 | 2015-07-31 | Anthrogenesis Corp | Method of producing erythrocytes without feeder cells |
CA2787992A1 (fr) * | 2010-01-26 | 2011-08-04 | Anthrogenesis Corporation | Traitement de cancers associes aux os utilisant des cellules souches placentaires |
EP3088512B1 (fr) | 2010-04-07 | 2019-12-11 | Celularity, Inc. | Utilisation de cellules souches placentaires pour traiter les maladies cardiovasculaires en favorisant l'angiogénèse |
MX2012011543A (es) | 2010-04-08 | 2013-05-06 | Anthrogenesis Corp | Tratamiento de sarcoidosis empleando celulas madre placentarias. |
CA2804750C (fr) | 2010-07-13 | 2022-05-10 | Anthrogenesis Corporation | Procedes de generation de cellules tueuses naturelles |
CA3138758A1 (fr) | 2010-09-28 | 2012-04-19 | Amylin Pharmaceuticals, Llc | Leptines hautement solubles |
AR093183A1 (es) | 2010-12-31 | 2015-05-27 | Anthrogenesis Corp | Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras |
EP3443968A1 (fr) | 2011-06-01 | 2019-02-20 | Celularity, Inc. | Traitement de la douleur à l'aide de cellules souches placentaires |
WO2013055476A1 (fr) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Traitement de la sclérose latérale amyotrophique au moyen de cellules souches placentaires |
CN115282165A (zh) | 2013-02-05 | 2022-11-04 | 细胞结构公司 | 来自胎盘的自然杀伤细胞 |
PT3334747T (pt) | 2015-08-13 | 2023-12-12 | Amgen Inc | Formulação de gonadotrofina líquida estável |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4165370A (en) | 1976-05-21 | 1979-08-21 | Coval M L | Injectable gamma globulin |
JPS5534001A (en) * | 1978-08-28 | 1980-03-10 | Noda Sangyo Kagaku Kenkyusho | Stabilization of sarcosine oxidase |
US4783441A (en) | 1979-04-30 | 1988-11-08 | Hoechst Aktiengesellschaft | Aqueous protein solutions stable to denaturation |
DE3176491D1 (en) | 1980-03-05 | 1987-11-26 | Miles Lab | Pasteurized therapeutically active protein compositions |
JPS5874617A (ja) | 1981-10-28 | 1983-05-06 | Green Cross Corp:The | 人由来血液凝固第7因子含有水溶液の加熱処理方法 |
JPS58134991A (ja) * | 1981-12-28 | 1983-08-11 | Takeda Chem Ind Ltd | セラチオペプチタ−ゼの安定化法 |
JPS59134730A (ja) | 1983-01-20 | 1984-08-02 | Green Cross Corp:The | 血液凝固第8因子の加熱処理法 |
FI86885C (fi) | 1984-04-20 | 1992-10-26 | Genentech Inc | Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill |
SE8501050D0 (sv) | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
CA1292686C (fr) | 1986-10-27 | 1991-12-03 | Ze'ev Shaked | Compositions pharmaceutiques d'interleukine-2 recombinante et procede de fabrication |
NZ226170A (en) | 1987-09-18 | 1990-07-26 | Ethicon Inc | Stable freeze-dried pharmaceutical composition containing epidermal growth factor |
CA1329760C (fr) * | 1987-10-29 | 1994-05-24 | Ted C. K. Lee | Formulation de plasma et de proteines recombinantes dans des milieux a grande force ionique |
US4877608A (en) * | 1987-11-09 | 1989-10-31 | Rorer Pharmaceutical Corporation | Pharmaceutical plasma protein formulations in low ionic strength media |
US5096885A (en) | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
EP0381345B1 (fr) | 1989-01-30 | 1994-07-13 | Corint, Ltd. | Composition aqueuse à base de desmopressine-CMC |
JPH02268681A (ja) * | 1989-04-07 | 1990-11-02 | Green Cross Corp:The | ウロキナーゼ前駆体の安定化方法及び乾燥製剤 |
WO1990012029A1 (fr) * | 1989-04-11 | 1990-10-18 | Immunobiology Research Institute, Inc. | Compositions de peptides lyophilisees |
AU6541090A (en) | 1989-10-16 | 1991-05-16 | Amgen, Inc. | Stem cell factor |
EP1241258A3 (fr) | 1989-10-16 | 2003-12-10 | Amgen Inc. | Facteur de stimulation de cellules souches |
SE465222C5 (sv) | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
DE4001451A1 (de) | 1990-01-19 | 1991-08-01 | Octapharma Ag | Stabile injizierbare loesungen von faktor viii und faktor ix |
AU8196891A (en) | 1990-06-25 | 1992-01-23 | Immunex Corporation | Mast cell growth factor |
CA2125855C (fr) * | 1991-12-20 | 2008-05-13 | Hans Holmegaard Sorensen | Formulation pharmaceutique stabilisee contenant de l'hormone de croissance et de l'histidine |
US5192743A (en) | 1992-01-16 | 1993-03-09 | Genentech, Inc. | Reconstitutable lyophilized protein formulation |
ES2154650T3 (es) * | 1992-10-02 | 2001-04-16 | Genetics Inst | Composicion que comprende una formulacion con factor de coagulacion viii, procedimiento para su preparacion y uso de un tensioactivo como estabilizador. |
-
1993
- 1993-12-22 US US08/172,507 patent/US6288030B1/en not_active Expired - Fee Related
-
1994
- 1994-12-20 IL IL11208894A patent/IL112088A/en not_active IP Right Cessation
- 1994-12-21 AU AU14422/95A patent/AU696860B2/en not_active Ceased
- 1994-12-21 CA CA002182970A patent/CA2182970C/fr not_active Expired - Fee Related
- 1994-12-21 AT AT95906058T patent/ATE173402T1/de not_active IP Right Cessation
- 1994-12-21 ES ES95906058T patent/ES2123951T3/es not_active Expired - Lifetime
- 1994-12-21 NZ NZ278252A patent/NZ278252A/en not_active IP Right Cessation
- 1994-12-21 DE DE69414723T patent/DE69414723T2/de not_active Expired - Lifetime
- 1994-12-21 CN CN94195012A patent/CN1105575C/zh not_active Expired - Fee Related
- 1994-12-21 WO PCT/US1994/014739 patent/WO1995017206A1/fr active IP Right Grant
- 1994-12-21 ZA ZA9410189A patent/ZA9410189B/xx unknown
- 1994-12-21 DK DK95906058T patent/DK0732935T3/da active
- 1994-12-21 EP EP95906058A patent/EP0732935B1/fr not_active Expired - Lifetime
-
1998
- 1998-06-29 US US09/106,891 patent/US5965522A/en not_active Expired - Fee Related
- 1998-07-31 HK HK98109572A patent/HK1008815A1/xx not_active IP Right Cessation
-
1999
- 1999-04-15 US US09/292,222 patent/US6020469A/en not_active Expired - Fee Related
-
2000
- 2000-12-20 US US09/748,592 patent/US20020013258A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6288030B1 (en) | 2001-09-11 |
CN1142771A (zh) | 1997-02-12 |
AU696860B2 (en) | 1998-09-17 |
US20020013258A1 (en) | 2002-01-31 |
EP0732935A1 (fr) | 1996-09-25 |
ES2123951T3 (es) | 1999-01-16 |
AU1442295A (en) | 1995-07-10 |
IL112088A0 (en) | 1995-03-15 |
NZ278252A (en) | 1998-04-27 |
CA2182970C (fr) | 2000-11-28 |
US5965522A (en) | 1999-10-12 |
WO1995017206A1 (fr) | 1995-06-29 |
DE69414723T2 (de) | 1999-07-22 |
EP0732935B1 (fr) | 1998-11-18 |
US6020469A (en) | 2000-02-01 |
CA2182970A1 (fr) | 1995-06-29 |
DE69414723D1 (de) | 1998-12-24 |
IL112088A (en) | 2001-04-30 |
ATE173402T1 (de) | 1998-12-15 |
ZA9410189B (en) | 1995-08-25 |
CN1105575C (zh) | 2003-04-16 |
DK0732935T3 (da) | 1999-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1008815A1 (en) | Lyophilized stem cell factor formulations | |
AU1777495A (en) | Stable freeze-dried formulation comprising a protein; assay kit | |
WO1995013297A3 (fr) | Compositions immunogenes ameliorees agissant contre la gastrine humaine 17 | |
CA2191213A1 (fr) | Souches de lactobacillus d'origine humaine, leurs compositions et leurs utilisations | |
AU1750097A (en) | Highly concentrated, lyophilized, and liquid factor ix formulations | |
IL110510A0 (en) | Pharmaceutical preparation containing a glucosidase and/or amylase inhibitor and a lipase inhibitor | |
DE3586697D1 (en) | Aktive thymopentin-analoga. | |
AU5327386A (en) | Peptide derivatives, analogous to pepstatin, which inhibit renin and acid proteases. | |
GR3006172T3 (fr) | ||
KR0180256B1 (en) | Bpc peptides, their preparation and use | |
AU6645294A (en) | L-amino acid oxidase | |
AU1384995A (en) | Human circulating cytokine cc-1 | |
IE873239L (en) | Variants of hirudin | |
AU570572B2 (en) | 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives | |
GR3031122T3 (en) | Stable lyophilized thiotepa composition. | |
AU7195787A (en) | Compositions stabilized with substituted amino carbamates and novel substituted amino carbamates | |
NZ326769A (en) | High-content famciclovir tablets | |
AU7969187A (en) | Amino acid composition | |
EP0219716A3 (fr) | Agent immunosuppresseur | |
AU2170695A (en) | Cloned glutamic acid decarboxylase | |
AU3573193A (en) | Recombinant plant enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20101221 |